{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:51Z","timestamp":1792788471259,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MRC Discovery Medicine North Doctoral Training Programme"},{"name":"Department of Defence"},{"DOI":"10.13039\/100019921","name":"National Scleroderma Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019921","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012331","name":"LEO Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Susan Cheney endowment for Scleroderma Research"},{"name":"NIHR BRC","award":["NIHR213331"],"award-info":[{"award-number":["NIHR213331"]}]},{"name":"NIHR BRC","award":["NIHR213331"],"award-info":[{"award-number":["NIHR213331"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic sclerosis (SSc) is a severe autoimmune disease characterised by progressive fibrosis driven by fibroblast activation. Primary cilia, key hubs for profibrotic signalling, are markedly shortened in SSc fibroblasts, but the mechanisms underlying this phenotype remain unclear. This study aimed to define the signalling pathways responsible for primary cilia shortening and fibroblast activation in SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Primary dermal fibroblasts from SSc patients and healthy controls were analysed for cilia incidence and length by immunofluorescence, profibrotic marker expression by qPCR, and contractility using gel contraction assays. Cells were treated with TGF\u03b21 and pharmacological inhibitors targeting AURKA, HDAC6, ROCK2, and Smad3 signalling. CAV1-silenced fibroblasts were used as an in vitro model of SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Maintenance of the constitutively short primary cilia phenotype in SSc fibroblasts did not require active TGF\u03b2 signalling. However, TGF\u03b21 induced reversible cilia shortening in healthy fibroblasts and further shortened cilia in SSc fibroblasts to a similar final length, mediated by Rho\/ROCK2 rather than canonical Smad3-dependent signalling. Constitutive cilia shortening in SSc was driven by aberrant AURKA activity upstream of HDAC6, promoting ciliary disassembly. Pharmacological inhibition of AURKA or HDAC6 selectively elongated cilia in SSc fibroblasts, reduced profibrotic marker expression, and abrogated fibroblast contractility, but it did not affect healthy control cells. CAV1-silenced fibroblasts similarly exhibited constitutive cilia shortening that was reversed by AURKA inhibition without affecting healthy cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The AURKA\/HDAC6 axis maintains short primary cilia and promotes fibroblast activation in SSc. These findings reveal a mechanistic link between cilia morphology and fibrosis and identify AURKA as a potential therapeutic target for SSc-associated tissue remodelling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-026-03826-6","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:36:30Z","timestamp":1778124990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aurora A kinase activation contributes to the fibrotic phenotype in systemic sclerosis through primary cilia shortening"],"prefix":"10.1186","volume":"28","author":[{"given":"Rebecca","family":"Wells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Caballero-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panji","family":"Mulipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Timmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Teves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Riobo-Del Galdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"1","key":"3826_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00281-025-01065-6","volume":"47","author":"A Lescoat","year":"2025","unstructured":"Lescoat A, et al. Systemic sclerosis: pathogenic mechanisms and their implications for treatment. Semin Immunopathol. 2025;47(1):39.","journal-title":"Semin Immunopathol"},{"issue":"11","key":"3826_CR2","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76(11):1897\u2013905.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3826_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","volume":"25","author":"FS Younesi","year":"2024","unstructured":"Younesi FS, et al. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat Rev Mol Cell Biol. 2024;25(8):617\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3826_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11926-012-0299-6","volume":"15","author":"C Beyer","year":"2013","unstructured":"Beyer C, Distler JH. Morphogen pathways in systemic sclerosis. Curr Rheumatol Rep. 2013;15(1):299.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"3826_CR5","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.celrep.2013.05.020","volume":"3","author":"CA Clement","year":"2013","unstructured":"Clement CA, et al. TGF-beta signaling is associated with endocytosis at the pocket region of the primary cilium. Cell Rep. 2013;3(6):1806\u201314.","journal-title":"Cell Rep"},{"key":"3826_CR6","doi-asserted-by":"crossref","unstructured":"Ho EK, Stearns T. Hedgehog signaling and the primary cilium: implications for spatial and temporal constraints on signaling. Development. 2021;148(9).","DOI":"10.1242\/dev.195552"},{"issue":"6","key":"3826_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/ncb2259","volume":"13","author":"MA Lancaster","year":"2011","unstructured":"Lancaster MA, Schroth J, Gleeson JG. Subcellular spatial regulation of canonical Wnt signalling at the primary cilium. Nat Cell Biol. 2011;13(6):700\u20137.","journal-title":"Nat Cell Biol"},{"issue":"20","key":"3826_CR8","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.cub.2005.09.012","volume":"15","author":"L Schneider","year":"2005","unstructured":"Schneider L, et al. PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. Curr Biol. 2005;15(20):1861\u20136.","journal-title":"Curr Biol"},{"key":"3826_CR9","doi-asserted-by":"crossref","unstructured":"Wachten D, Christensen ST. Primary cilia signalling at a glance. J Cell Sci. 2025;138(20).","DOI":"10.1242\/jcs.264187"},{"key":"3826_CR10","doi-asserted-by":"crossref","unstructured":"Wang L, Dynlacht BD. The regulation of cilium assembly and disassembly in development and disease. Development. 2018;145(18).","DOI":"10.1242\/dev.151407"},{"key":"3826_CR11","doi-asserted-by":"publisher","first-page":"8087","DOI":"10.1038\/ncomms9087","volume":"6","author":"S Kim","year":"2015","unstructured":"Kim S, et al. Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle. Nat Commun. 2015;6:8087.","journal-title":"Nat Commun"},{"issue":"4","key":"3826_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrm3085","volume":"12","author":"H Ishikawa","year":"2011","unstructured":"Ishikawa H, Marshall WF. Ciliogenesis: building the cell\u2019s antenna. Nat Rev Mol Cell Biol. 2011;12(4):222\u201334.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"3826_CR13","doi-asserted-by":"publisher","first-page":"e70060","DOI":"10.1002\/bies.70060","volume":"47","author":"CM Ott","year":"2025","unstructured":"Ott CM, Mukhopadhyay S. Taking Down the Primary Cilium: Pathways for Disassembly in Differentiating Cells. BioEssays. 2025;47(11):e70060.","journal-title":"BioEssays"},{"issue":"6","key":"3826_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11926-019-0822-0","volume":"21","author":"ME Teves","year":"2019","unstructured":"Teves ME, et al. The Primary Cilium: Emerging Role as a Key Player in Fibrosis. Curr Rheumatol Rep. 2019;21(6):29.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"3826_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/BOR.0000000000000841","volume":"33","author":"D Bhattacharyya","year":"2021","unstructured":"Bhattacharyya D, Teves ME, Varga J. The dynamic organelle primary cilia: emerging roles in organ fibrosis. Curr Opin Rheumatol. 2021;33(6):495\u2013504.","journal-title":"Curr Opin Rheumatol"},{"key":"3826_CR16","doi-asserted-by":"crossref","unstructured":"Verma P et al. Morphological reprogramming of primary cilia length mitigates the fibrotic phenotype in fibroblasts across diverse fibrotic conditions. J Cell Sci. 2025.","DOI":"10.15252\/rc.2025156516"},{"issue":"1","key":"3826_CR17","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1038\/s41598-018-29502-7","volume":"8","author":"DT Rowson","year":"2018","unstructured":"Rowson DT, et al. Mechanical loading induces primary cilia disassembly in tendon cells via TGFbeta and HDAC6. Sci Rep. 2018;8(1):11107.","journal-title":"Sci Rep"},{"issue":"1","key":"3826_CR18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41598-018-38020-5","volume":"9","author":"L Rangel","year":"2019","unstructured":"Rangel L, et al. Caveolin-1alpha regulates primary cilium length by controlling RhoA GTPase activity. Sci Rep. 2019;9(1):1116.","journal-title":"Sci Rep"},{"issue":"1","key":"3826_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1091\/mbc.12.1.27","volume":"12","author":"NA Bhowmick","year":"2001","unstructured":"Bhowmick NA, et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001;12(1):27\u201336.","journal-title":"Mol Biol Cell"},{"issue":"7","key":"3826_CR20","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","volume":"129","author":"EN Pugacheva","year":"2007","unstructured":"Pugacheva EN, et al. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell. 2007;129(7):1351\u201363.","journal-title":"Cell"},{"issue":"9","key":"3826_CR21","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/art.23791","volume":"58","author":"F Del Galdo","year":"2008","unstructured":"Del Galdo F, et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum. 2008;58(9):2854\u201365.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3826_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/BOR.0b013e3283103d27","volume":"20","author":"F Del Galdo","year":"2008","unstructured":"Del Galdo F, Lisanti MP, Jimenez SA. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol. 2008;20(6):713\u20139.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"3826_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/annrheumdis-2011-200986","volume":"71","author":"M Manetti","year":"2012","unstructured":"Manetti M, et al. Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis. Ann Rheum Dis. 2012;71(6):1034\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3826_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1755-1536-4-15","volume":"4","author":"E Tourkina","year":"2011","unstructured":"Tourkina E, et al. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair. 2011;4(1):15.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"14","key":"3826_CR25","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1091\/mbc.e11-12-1056","volume":"23","author":"OV Plotnikova","year":"2012","unstructured":"Plotnikova OV, et al. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Mol Biol Cell. 2012;23(14):2658\u201370.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"3826_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1183\/09031936.00090511","volume":"40","author":"V Sathish","year":"2012","unstructured":"Sathish V, et al. Caveolin-1 regulation of store-operated Ca(2+) influx in human airway smooth muscle. Eur Respir J. 2012;40(2):470\u20138.","journal-title":"Eur Respir J"},{"issue":"2","key":"3826_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1254\/jphs.FP0071192","volume":"106","author":"H Zhu","year":"2008","unstructured":"Zhu H, et al. Caveolae\/caveolin-1 are important modulators of store-operated calcium entry in Hs578\/T breast cancer cells. J Pharmacol Sci. 2008;106(2):287\u201394.","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"3826_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1083\/jcb.201106101","volume":"197","author":"A Inoko","year":"2012","unstructured":"Inoko A, et al. Trichoplein and Aurora A block aberrant primary cilia assembly in proliferating cells. J Cell Biol. 2012;197(3):391\u2013405.","journal-title":"J Cell Biol"},{"issue":"2","key":"3826_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jid.2022.08.052","volume":"143","author":"P Sapao","year":"2023","unstructured":"Sapao P, et al. Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis. J Invest Dermatol. 2023;143(2):284\u201393.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"3826_CR30","doi-asserted-by":"publisher","first-page":"e0125936","DOI":"10.1371\/journal.pone.0125936","volume":"10","author":"ME Teves","year":"2015","unstructured":"Teves ME, et al. Spag17 deficiency results in skeletal malformations and bone abnormalities. PLoS ONE. 2015;10(5):e0125936.","journal-title":"PLoS ONE"},{"issue":"11","key":"3826_CR31","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3826_CR32","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/ard.2010.136929","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac J, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70(3):476\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3826_CR33","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1093\/rheumatology\/keae698","volume":"64","author":"RL Ross","year":"2025","unstructured":"Ross RL, et al. Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Rheumatology (Oxford). 2025;64(6):3606\u201317.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3826_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/art.40437","volume":"70","author":"J Gillespie","year":"2018","unstructured":"Gillespie J, et al. Transforming Growth Factor beta Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2. Arthritis Rheumatol. 2018;70(6):932\u201342.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3826_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/annrheumdis-2017-212120","volume":"77","author":"V Liakouli","year":"2018","unstructured":"Liakouli V, et al. Scleroderma fibroblasts suppress angiogenesis via TGF-beta\/caveolin-1 dependent secretion of pigment epithelium-derived factor. Ann Rheum Dis. 2018;77(3):431\u201340.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03826-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03826-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03826-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:37:54Z","timestamp":1782776274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03826-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3826"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03826-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2026.03.13.711548","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as part of the observational study STRIKE, approved by NorthEast-Newcastle & North Tyneside 2 Research Ethics Committee (IRAS ID: 178638; REC Reference: 15\/NE\/0211). All participants voluntarily agreed to participate providing written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}